Replies to post #788421 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

I agree. It will certainly be after mid 2027 but most likely in 2028 given the pace with which NWBO does things.

No evidence submission in parallel with MAA only tells you that NICE isn’t likely to approve quickly. Otherwise they would have jumped on it and submitted in 2024.

Similar to the FDA story. They know that FDA is unlikely to consider their application with the current data and framework. So they chose not to apply. Even though its over 50% of the world’s revenue as opposed to less than 5% in the UK.

This will be an excellent way for shorts and LP’s financiers to make a ton of money again as soon as LP announces increase in authorized share count because they know that NWBO is going to continue to disappoint on the next steps and dilute endlessly for many more years.

[space~farm]

Barnuuuk has absolutely no idea what he is talking about but whatever, let him influence idiots.